Takero Shindo

1.1k total citations
59 papers, 620 citations indexed

About

Takero Shindo is a scholar working on Hematology, Immunology and Genetics. According to data from OpenAlex, Takero Shindo has authored 59 papers receiving a total of 620 indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Hematology, 29 papers in Immunology and 12 papers in Genetics. Recurrent topics in Takero Shindo's work include Immune Cell Function and Interaction (14 papers), Hematopoietic Stem Cell Transplantation (13 papers) and Chronic Myeloid Leukemia Treatments (9 papers). Takero Shindo is often cited by papers focused on Immune Cell Function and Interaction (14 papers), Hematopoietic Stem Cell Transplantation (13 papers) and Chronic Myeloid Leukemia Treatments (9 papers). Takero Shindo collaborates with scholars based in Japan, United States and India. Takero Shindo's co-authors include Shinya Kimura, Hiroshi Ureshino, Akifumi Takaori‐Kondo, Yutaka Shimazu, Sumie Fujii, Shigeo Fuji, Yasuo Miura, Taira Maekawa, Hideyo Hirai and Tatsuo Ichinohe and has published in prestigious journals such as Blood, Cell stem cell and Frontiers in Immunology.

In The Last Decade

Takero Shindo

54 papers receiving 616 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Takero Shindo Japan 12 236 220 180 154 138 59 620
Yoshihito Hayami Japan 13 155 0.7× 161 0.7× 169 0.9× 99 0.6× 154 1.1× 26 583
Mark Biondo Australia 14 165 0.7× 297 1.4× 110 0.6× 75 0.5× 183 1.3× 25 702
Hande H. Tuncer United States 8 155 0.7× 243 1.1× 100 0.6× 205 1.3× 200 1.4× 16 552
Keisuke Kawamoto Japan 14 99 0.4× 215 1.0× 60 0.3× 142 0.9× 245 1.8× 48 646
Takeki Mitsui Japan 14 203 0.9× 222 1.0× 236 1.3× 100 0.6× 113 0.8× 60 688
Pilar Hernández-Campo Spain 12 435 1.8× 300 1.4× 199 1.1× 191 1.2× 127 0.9× 16 889
Naoki Kurita Japan 12 110 0.5× 139 0.6× 93 0.5× 74 0.5× 91 0.7× 60 471
Hervé Dombret France 10 640 2.7× 86 0.4× 255 1.4× 142 0.9× 241 1.7× 11 911
Panayotis Kaloyannidis Greece 15 168 0.7× 171 0.8× 131 0.7× 217 1.4× 132 1.0× 41 628
Markus Müschen United States 13 171 0.7× 312 1.4× 400 2.2× 72 0.5× 195 1.4× 20 884

Countries citing papers authored by Takero Shindo

Since Specialization
Citations

This map shows the geographic impact of Takero Shindo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takero Shindo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takero Shindo more than expected).

Fields of papers citing papers by Takero Shindo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takero Shindo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takero Shindo. The network helps show where Takero Shindo may publish in the future.

Co-authorship network of co-authors of Takero Shindo

This figure shows the co-authorship network connecting the top 25 collaborators of Takero Shindo. A scholar is included among the top collaborators of Takero Shindo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takero Shindo. Takero Shindo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Morizane, Asuka, Takero Shindo, Takayuki Anazawa, et al.. (2025). Control of immune response in an iPSC-based allogeneic cell therapy clinical trial for Parkinson’s disease. Cell stem cell. 32(9). 1346–1355.e3. 1 indexed citations
2.
3.
Shindo, Takero, et al.. (2023). Tucidinostat restores CCR4 expression in adult T-cell leukemia/lymphoma. Haematologica. 109(3). 1007–1009. 2 indexed citations
4.
Ureshino, Hiroshi, et al.. (2022). Favorable HLA Polymorphisms are Associated with Lower Molecular Relapse after Tyrosine Kinase Discontinuation in Patients with Chronic Myeloid Leukemia. Indian Journal of Hematology and Blood Transfusion. 38(4). 760–761. 1 indexed citations
5.
Shindo, Takero, Kaori Nakayama‐Hosoya, Koshi Akahane, et al.. (2021). KIR3DL1 Allotype-Dependent Modulation of NK Cell Immunity against Chronic Myeloid Leukemia. ImmunoHorizons. 5(8). 687–702. 4 indexed citations
6.
Okamura, Hiroshi, Hirohisa Nakamae, Takero Shindo, et al.. (2021). Early Elevation of Complement Factor Ba Is a Predictive Biomarker for Transplant-Associated Thrombotic Microangiopathy. Frontiers in Immunology. 12. 695037–695037. 22 indexed citations
7.
Ureshino, Hiroshi, Takero Shindo, Hidenori Tanaka, Hiroh Saji, & Shinya Kimura. (2020). HLA Polymorphisms Are Associated with Treatment-Free Remission Following Discontinuation of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia. Molecular Cancer Therapeutics. 20(1). 142–149. 13 indexed citations
8.
Tsuji, Hideaki, Hajime Yoshifuji, Takero Shindo, et al.. (2020). Primary hepatic lymphoma as other iatrogenic immunodeficiency-related lymphoproliferative disorders: a case report and review of the literature. Modern Rheumatology Case Reports. 5(1). 172–177. 5 indexed citations
9.
Kurosawa, Saiko, Hiroki Yamaguchi, Takuhiro Yamaguchi, et al.. (2020). The prognostic impact of FLT3-ITD, NPM1 and CEBPa in cytogenetically intermediate-risk AML after first relapse. International Journal of Hematology. 112(2). 200–209. 10 indexed citations
10.
Shindo, Takero, Toyofumi F. Chen‐Yoshikawa, Akihiko Yoshizawa, et al.. (2019). Trametinib Attenuates Delayed Rejection and Preserves Thymic Function in Rat Lung Transplantation. American Journal of Respiratory Cell and Molecular Biology. 61(3). 355–366. 10 indexed citations
11.
Ureshino, Hiroshi, Takero Shindo, & Shinya Kimura. (2019). Role of cancer immunology in chronic myelogenous leukemia. Leukemia Research. 88. 106273–106273. 23 indexed citations
12.
Ureshino, Hiroshi, Takero Shindo, Hiroto Kojima, et al.. (2018). Allelic Polymorphisms of KIR s and HLA s Predict Favorable Responses to Tyrosine Kinase Inhibitors in CML. Cancer Immunology Research. 6(6). 745–754. 26 indexed citations
13.
Fukushima, Noriyasu, Masako Yokoo, Takero Shindo, et al.. (2018). Monitoring of citrulline and diamine oxidase levels as biomarkers for intestinal mucositis during early-phase hematopoietic cell transplantation. PubMed Central. 1(1). 1 indexed citations
14.
Ureshino, Hiroshi, Hidekazu Itamura, Mariko Yoshimura, et al.. (2018). Clinical impact of the CONUT score and mogamulizumab in adult T cell leukemia/lymphoma. Annals of Hematology. 98(2). 465–471. 22 indexed citations
15.
Itamura, Hidekazu, Yasushi Kubota, Takero Shindo, et al.. (2017). Elderly Patients With Chronic Myeloid Leukemia Benefit From a Dasatinib Dose as Low as 20 mg. Clinical Lymphoma Myeloma & Leukemia. 17(6). 370–374. 15 indexed citations
16.
Ureshino, Hiroshi, Takero Shindo, Hiroyoshi Nishikawa, et al.. (2016). Effector Regulatory T Cells Reflect the Equilibrium between Antitumor Immunity and Autoimmunity in Adult T-cell Leukemia. Cancer Immunology Research. 4(8). 644–649. 24 indexed citations
17.
Fuji, Shigeo & Takero Shindo. (2016). Friend or foe? Mogamulizumab in allogeneic hematopoietic stem cell transplantation for adult T-cell leukemia/lymphoma. PubMed. 3. 70–70. 32 indexed citations
18.
Sueoka, Eisaburo, Yasushi Kubota, Hidekazu Itamura, et al.. (2013). MANAGEMENT OF TRANSFUSIONAL IRON OVERLOAD. Japanese Journal of Transfusion and Cell Therapy. 59(1). 73–78. 1 indexed citations
19.
Shindo, Takero, Takayuki Ishikawa, Akiko Fukunaga, Toshiyuki Hori, & Takashi Uchiyama. (2008). Growth and Differentiation Advantages of CD4+OX40+ T Cells from Allogeneic Hematopoietic Stem Cell Transplantation Recipients. Biology of Blood and Marrow Transplantation. 14(3). 268–281. 5 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yoshihito Hayami Breakdown of academic impact, for papers by Mark Biondo Breakdown of academic impact, for papers by Hande H. Tuncer Breakdown of academic impact, for papers by Keisuke Kawamoto Breakdown of academic impact, for papers by Takeki Mitsui Breakdown of academic impact, for papers by Pilar Hernández-Campo Breakdown of academic impact, for papers by Naoki Kurita Breakdown of academic impact, for papers by Hervé Dombret Breakdown of academic impact, for papers by Panayotis Kaloyannidis Breakdown of academic impact, for papers by Markus Müschen
Rankless by CCL
2026